Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sezary syndrome-Reference-Cited by-同舟云学术

Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sezary syndrome

Published:2005-11 Issue:6 Volume:30 Page:702-706
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Exp Dermatol

Author:

Sokolowska-Wojdylo M.,Wenzel J.,Gaffal E.,Steitz J.,Roszkiewicz J.,Bieber T.,Tuting T.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2230.2005.01904.x/fullpdf

Reference18 articles.

1. A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy

2. Comparative analysis of histologicai and immunohistological features in mycosis fungoides and Sezary syndrome

3. Circulating clonal CLA+ and CD4+ T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7

4. Absence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in Peripheral Blood

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2022-10-20

2. Malignant and Benign T Cells Constituting Cutaneous T-Cell Lymphoma;International Journal of Molecular Sciences;2021-11-29

3. The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells;Cancers;2021-11-26

4. Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2021-08-02

5. Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome;Journal of Investigative Dermatology;2021-03